Fate Therapeutics FATE
NASDAQ FATE
$2.32 +0.02 (+0.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Fate Therapeutics (FATE) recorded Return on Capital Employed [ROCE] of -55.68% in Q2 2026, down 1.72 percentage points from -53.96% a year earlier and down 4.28 percentage points from the prior quarter.

Analysis

Fate Therapeutics (FATE) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025, Fate Therapeutics reported Return on Capital Employed [ROCE] of -42.97%, up 5.38 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -8.98 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -48.35% in FY2024 (-14.73 pp), -33.61% in FY2023 (+10.48 pp), -44.09% in FY2022 (-12.67 pp) and -31.42% in FY2021 (+2.57 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q2 2018.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for eight consecutive quarters, with an average year-over-year change of -6.27 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 11.07 percentage points in Q4 2023, against a drop of 26.54 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -51.40% (Q1 2026), -50.03% (Q4 2025) and -53.02% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Fate Therapeutics 270.73 Mn 270.73 Mn - -55.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.68%
Mar 31, 2026 -51.40%
Dec 31, 2025 -50.03%
Sep 30, 2025 -53.02%
Jun 30, 2025 -53.96%
Mar 31, 2025 -51.21%
Dec 31, 2024 -48.98%
Sep 30, 2024 -41.44%
Jun 30, 2024 -37.99%
Mar 31, 2024 -43.23%
Dec 31, 2023 -39.21%
Sep 30, 2023 -39.56%
Jun 30, 2023 -42.99%
Mar 31, 2023 -42.39%
Dec 31, 2022 -50.27%
Sep 30, 2022 -46.47%
Jun 30, 2022 -37.99%
Mar 31, 2022 -30.20%
Dec 31, 2021 -24.89%
Sep 30, 2021 -19.93%
API Access

Fate Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FATE&period=max&api_key=YOUR_API_KEY